H
HotSpot Therapeutics
Discovering new allosteric therapies with the ability to treat disease in new ways
About HotSpot Therapeutics
HotSpot Therapeutics is a biotechnology startup that is revolutionizing the field of allosteric drug discovery. The company's primary focus is on developing innovative medicines by targeting "natural hotspots" - the on/off switches on proteins. These switches play a crucial role in a protein's function and can be manipulated to combat diseases. HotSpot's unique approach to drug discovery could potentially lead to new treatments for cancer and autoimmune diseases.
The company operates in the pharmaceutical market, serving a broad range of clients, including healthcare providers and patients. HotSpot's business model revolves around its proprietary Smart Allostery™ platform, which combines structure-function analysis, advanced pharmacology, tailored chemistry, and artificial intelligence. This platform allows the company to systematically uncover and drug natural hotspots, leading to the discovery of novel allosteric medicines.
HotSpot generates revenue through the development and sale of these innovative drugs. The company's pipeline, as of November 2023, suggests a promising future with potential new treatments on the horizon.
Source: Dealroom company dataNews
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Nov 2021 | $100M | $400M | Atlas Venture · EQT Life Sciences · MRL Ventures · Monashee Investment Management | ↗ |
| SERIES BOther financing | May 2020 | $65M | $132M | Sofinnova Partners · MRL Ventures · Solasta Ventures · Atlas Venture | ↗ |
Growth signals
Latest recorded traffic for HotSpot Therapeutics is 2.9K monthly website visits, up 3.6% over the last three months. HotSpot Therapeutics's team declined 1.6% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
HotSpot Therapeutics in the Boston ecosystem
The HotSpot Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Series A7 investors entered at this stage
Atlas Venture
Sofinnova InvestmentsSR One
MRL Ventures
Solasta Ventures- TMTekla Capital Management
Brace Pharma
Series B and later7 investors entered at this stage
Pivotal Life Sciences
EQT Life Sciences
Monashee Investment Management
CaaS Capital Management- PCPavilion Capital
B Capital
Revelation Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about HotSpot Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See HotSpot Therapeutics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










